Despite the fact that different administration routes and delivery systems have been used for interleukin-2 (IL-2) delivery, little has been reported regarding the most efficient strategies used to deliver IL-2 in a nontoxic, efficient, stable and safe manner. Systemic IL-2 administration has always
Interferon-γ therapy: Evaluation of routes of administration and delivery systems
✍ Scribed by Husam M. Younes; Brian G. Amsden
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 200 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
✦ Synopsis
Although different routes and delivery systems have been used to deliver interferon-g (IFN-g) for the treatment of a variety of viral and neoplastic diseases, little has been reported regarding the most ef®cient and least toxic routes and drug delivery modes required to achieve these goals. To have a greater understanding of the best strategies to use to administer this cytokine in an ef®cient, stable, and safe manner, this review details aspects of IFN-g concerning its mechanism of action, physical properties, and pharmacokinetics. One important conclusion that is drawn from this analysis is that a consistent, local concentration of IFN-g is necessary to achieve an optimal therapeutic response. A critical discussion covering the advantages and limitations of the currently used methodologies to deliver IFN-g in such a fashion is presented. ß 2002
📜 SIMILAR VOLUMES
Over the past few decades alternate routes of administration have gained significant momentum and attention, to complement approved drug products, or enable those that cannot be delivered by the oral or parenteral route. Intranasal, buccal/ sublingual, pulmonary, and transdermal routes being the mos
Gene delivery of mouse interferon (IFN) ( has been shown to inhibit metastatic tumor growth and onset of atopic dermatitis in mouse models. In this study, we tried to increase the circulation half-life of IFN( after its gene delivery by designing a novel fusion protein of IFN( with mouse serum album